Aucatzyl® (obecabtagene autoleucel) – New orphan drug approval
November 8, 2024 - The FDA announced the approval of Autolus’ Aucatzyl (obecabtagene autoleucel), for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
Download PDF
